Mical Paul

Researcher Next ID · RN-010991

Researcher · Biochemistry, Genetics and Molecular Biology

, Israel

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Medicine

Antibiotic Resistance in Bacteria

Bacterial Identification and Susceptibility Testing

Antibiotic Use and Resistance

Antibiotics Pharmacokinetics and Efficacy

Neutropenia and Cancer Infections

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
Clinical Microbiology and Infection · 2021 · 10.1016/j.cmi.2021.11.025
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 10.1002/phar.2209
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
The Lancet Infectious Diseases · 2018 · 10.1016/s1473-3099(18)30099-9
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
The Lancet Respiratory Medicine · 2014 · 10.1016/s2213-2600(14)70041-4
Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis
Antimicrobial Agents and Chemotherapy · 2010 · 10.1128/aac.00627-10

No projects listed.